Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RA1v1nK-_4Kad8Di7ZAtU10nYFCorkl1MVl1e5XUqpFE8#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "alogliptin tablets are a dipeptidyl peptidase 4 dpp 4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus 1 1 14 important limitations of use not for treatment of type 1 diabetes or diabetic ketoacidosis 1 1 alogliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies 14 important limitations of use alogliptin tablets are not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis as it would not be effective in these settings" assertion.
- association object DOID_9352 assertion.
- association predicate treats assertion.
- DOID_9352 category Disease assertion.
- drugbank:DB06203 category Drug assertion.
- association subject drugbank:DB06203 assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.
- association relation TreatmentIndication assertion.